The inhaled corticosteroid medication budesonide, widely used for the treatment of asthma, has been found to aid the recovery of COVID-19 patients when administered at home.
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Nephron Pharmaceuticals Corporation due to emails Nephron’s CEO and a sales representative sent concerning its product Budesonide Inhalation Suspension ...